https://www.divergentpatentlaw.com/zh/post/重新审视专利适格性：从日本-技术性-理论视角解读美国-101-判例法 2026-06-12 https://static.wixstatic.com/media/dac807_3e9395fa69e641d2a76e33569b34e1d6~mv2.jpg https://www.divergentpatentlaw.com/zh/post/美国和中国专利法中的权利要求范围与公开：书面描述、说明书支持、充分公开以及审查-审理的场域特定性 2026-06-22 https://static.wixstatic.com/media/dac807_8ef5a81d88284d29a868b806898c84f6~mv2.jpg https://www.divergentpatentlaw.com/zh/post/跨机构信息一致性：如何协调-fda-与-uspto-的陈述以避免不诚信行为及监管风险 2026-06-12 https://static.wixstatic.com/media/dac807_3c207f5d29b1408595694112cd96882d~mv2.jpg https://www.divergentpatentlaw.com/zh/post/一项设计，两套制度：lkq之后美国与欧盟的外观设计保护 2026-07-22 https://static.wixstatic.com/media/dac807_235c43de7c514f5da1f7b0d202c7a2ea~mv2.jpg https://www.divergentpatentlaw.com/zh/post/审查员不是对方律师作为调解式代理的专利申请审查 2026-07-14 https://static.wixstatic.com/media/dac807_da53484f28934049973102e9aa7881f2~mv2.jpg https://www.divergentpatentlaw.com/zh/post/专利审查上诉的-翻译-：比较uspto-ptab上诉与jpo不服审查员驳回决定的上诉 2026-07-18 https://static.wixstatic.com/media/dac807_d2e9d511763a404c9957eaf07a4fa869~mv2.jpg https://www.divergentpatentlaw.com/zh/post/同一份-office-action，不同的利害关系：在单方再审查与普通专利审查中答复-uspto-office-action 2026-07-04 https://static.wixstatic.com/media/dac807_439071df6a5d400a9ac01fd10bc95c6a~mv2.jpg https://www.divergentpatentlaw.com/zh/post/为本领域技术人员而写，供所有人阅读面向多重读者的专利申请撰写 2026-07-20 https://static.wixstatic.com/media/dac807_fe3bd939f02f437d87f317db38d81814~mv2.jpg https://www.divergentpatentlaw.com/zh/post/错在映射，并非小型审理：uspto-新设再审查命令前书面程序的案例研究 2026-07-16 https://static.wixstatic.com/media/dac807_338cf61710db4ca0a86305283a22a47d~mv2.jpg https://www.divergentpatentlaw.com/zh/post/跨领域现有技术与事后分析：美国类似现有技术法理与epo问题-解决方案法 2026-06-25 https://static.wixstatic.com/media/dac807_0bb0fc2f35c24fb289d64454681df8ba~mv2.jpg https://www.divergentpatentlaw.com/zh/post/属地陷阱：美国和中国来源发明的外国申请限制 2026-07-08 https://static.wixstatic.com/media/dac807_1bb2055bfc7f4d108e2ded8bbb20c52d~mv2.jpg https://www.divergentpatentlaw.com/zh/post/全球审查员面谈：uspto、epo、jpo、韩国和中国专利局中的沟通、承诺与审查历史风险 2026-07-06 https://static.wixstatic.com/media/11062b_b2752c8c6f55484e8b230ba3cac64394~mv2.jpg https://www.divergentpatentlaw.com/zh/post/保持专利族开放：美国继续申请实务与欧洲、中国、韩国和日本的比较 2026-07-12 https://static.wixstatic.com/media/dac807_c63fb7504be04a578fc06cf559b1100b~mv2.jpeg https://www.divergentpatentlaw.com/zh/post/精益专利运营：专利申请与审查工作流中的自働化、自动化与人工智能 2026-06-23 https://static.wixstatic.com/media/dac807_dfede13305814af39b7cdb6e732b191b~mv2.jpg https://www.divergentpatentlaw.com/zh/post/韩国和美国的专利期限救济：区分专利局延误与监管延误 2026-06-29 https://static.wixstatic.com/media/dac807_60ba1028e7e3466c985a93467017b6a4~mv2.jpg https://www.divergentpatentlaw.com/zh/post/uspto-2026年指南之后的smed：规则132声明、佐证，以及建立可经受法院审查的-101记录的必要性 2026-07-02 https://static.wixstatic.com/media/dac807_ba9f502efd994365a92247dc81a754c3~mv2.jpg https://www.divergentpatentlaw.com/zh/post/uspto和epo中的秘密现有技术：先申请、后公开专利申请的比较视角 2026-07-10 https://static.wixstatic.com/media/dac807_153d5fd3c82a40a5a93aa0d5237b01a8~mv2.jpg https://www.divergentpatentlaw.com/zh/post/超越排除权：大型公司为何取得其可能永不主张的专利 2026-07-24 https://static.wixstatic.com/media/dac807_84a1cc482e5a4ab28934f53b825fd7db~mv2.jpeg https://www.divergentpatentlaw.com/zh/post/限制性条款作为实质性限制：从focus-products诉kartri案中汲取的经验教训 2026-06-11 https://static.wixstatic.com/media/dac807_c4b766e659fc4af8a0f5c8b5982d35d3~mv2.jpg https://www.divergentpatentlaw.com/zh/post/三个月期限是兜底保障，而不是提交目标日 2026-06-21 https://static.wixstatic.com/media/dac807_76cf98d3389d46e0a0e695af6f96d15a~mv2.jpeg https://www.divergentpatentlaw.com/zh/post/坦诚而不让步：提交信息披露声明的理念依据 2026-06-19 https://static.wixstatic.com/media/dac807_752411e350e640c6bcda2946254d6dac~mv2.jpg https://www.divergentpatentlaw.com/zh/post/在美国-pct-实务中选择-371-国家阶段还是旁路继续申请 2026-06-16 https://static.wixstatic.com/media/dac807_bcb7d9544fdd438ba3db773f4a2025fc~mv2.jpeg